These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22118372)

  • 1. Relation between the frequency of CD34⁺ bone marrow derived circulating progenitor cells and the number of diseased coronary arteries in patients with myocardial ischemia and diabetes.
    Bozdag-Turan I; Turan RG; Turan CH; Ludovicy S; Akin I; Kische S; Arsoy NS; Schneider H; Ortak J; Rehders T; Hermann T; Paranskaya L; Kohlschein P; Bastian M; Ulus AT; Sahin K; Ince H; Nienaber CA
    Cardiovasc Diabetol; 2011 Nov; 10():107. PubMed ID: 22118372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between the functional impairment of bone marrow-derived circulating progenitor cells and the extend of coronary artery disease.
    Bozdag-Turan I; Turan RG; Paranskaya L; Arsoy NS; Turan CH; Akin I; Kische S; Ortak J; Schneider H; Ludovicy S; Hermann T; D'Ancona G; Durdu S; Akar AR; Ince H; Nienaber CA
    J Transl Med; 2012 Jul; 10():143. PubMed ID: 22776510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired mobilization of CD133(+) bone marrow-derived circulating progenitor cells with an increased number of diseased coronary arteries in ischemic heart disease patients with diabetes.
    Turan RG; Turan CH; Bozdag-Turan I; Ortak J; Akin I; Kische S; Schneider H; Kleinfeldt T; Rehders TC; Rauchhaus M; Adolph E; Amen S; Hermann T; Yokus S; Brehm M; Steiner S; Sahin K; Nienaber CA; Ince H
    Circ J; 2011; 75(11):2635-41. PubMed ID: 21828932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved mobilization of the CD34(+) and CD133(+) bone marrow-derived circulating progenitor cells by freshly isolated intracoronary bone marrow cell transplantation in patients with ischemic heart disease.
    Turan RG; Bozdag-Turan I; Ortak J; Akin I; Kische S; Schneider H; Turan CH; Rehders TC; Rauchhaus M; Kleinfeldt T; Adolph E; Brehm M; Yokus S; Steiner S; Sahin K; Nienaber CA; Ince H
    Stem Cells Dev; 2011 Sep; 20(9):1491-501. PubMed ID: 21190450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing spontaneous mobilization of CD34+ and CD133+ progenitor cells after myocardial infarction.
    Turan RG; Brehm M; Koestering M; Tobias Z; Bartsch T; Steiner S; Picard F; Ebner P; Schannwell CM; Strauer BE
    Eur J Clin Invest; 2007 Nov; 37(11):842-51. PubMed ID: 17973780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating progenitor cells and coronary microvascular dysfunction: Results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction Study (WISE-CVD).
    Mekonnen G; Hayek SS; Mehta PK; Li Q; Mahar E; Mou L; Kenkre TS; Petersen JW; Azarbal B; Samuels B; Anderson RD; Sedlak T; Zaya M; Agarwal M; Haftbaradaran A; Minissian M; Handberg E; Pepine CJ; Cogle CR; Bairey Merz CN; Waller EK; Quyyumi AA
    Atherosclerosis; 2016 Oct; 253():111-117. PubMed ID: 27596135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes.
    Cogle CR; Wise E; Meacham AM; Zierold C; Traverse JH; Henry TD; Perin EC; Willerson JT; Ellis SG; Carlson M; Zhao DX; Bolli R; Cooke JP; Anwaruddin S; Bhatnagar A; da Graca Cabreira-Hansen M; Grant MB; Lai D; Moyé L; Ebert RF; Olson RE; Sayre SL; Schulman IH; Bosse RC; Scott EW; Simari RD; Pepine CJ; Taylor DA;
    Circ Res; 2014 Oct; 115(10):867-74. PubMed ID: 25136078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated cellular senescence as underlying mechanism for functionally impaired bone marrow-derived progenitor cells in ischemic heart disease.
    Nollet E; Hoymans VY; Rodrigus IR; De Bock D; Dom M; Van Hoof VOM; Vrints CJ; Van Craenenbroeck EM
    Atherosclerosis; 2017 May; 260():138-146. PubMed ID: 28434530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progenitor Cells and Clinical Outcomes in Patients With Acute Coronary Syndromes.
    Samman Tahhan A; Hammadah M; Raad M; Almuwaqqat Z; Alkhoder A; Sandesara PB; Mohamed-Kelli H; Hayek SS; Kim JH; O'Neal WT; Topel ML; Grant AJ; Sabbak N; Heinl RE; Gafeer MM; Obideen M; Kaseer B; Abdelhadi N; Ko YA; Liu C; Hesaroieh I; Mahar EA; Vaccarino V; Waller EK; Quyyumi AA
    Circ Res; 2018 May; 122(11):1565-1575. PubMed ID: 29514830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced mobilization of the bone marrow-derived circulating progenitor cells by intracoronary freshly isolated bone marrow cells transplantation in patients with acute myocardial infarction.
    Turan RG; Bozdag-T I; Turan CH; Ortak J; Akin I; Kische S; Schneider H; Rauchhaus M; Rehders TC; Kleinfeldt T; Belu C; Amen S; Hermann T; Yokus S; Brehm M; Steiner S; Chatterjee T; Sahin K; Nienaber CA; Ince H
    J Cell Mol Med; 2012 Apr; 16(4):852-64. PubMed ID: 21707914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone Marrow-Derived Progenitor Cells Are Functionally Impaired in Ischemic Heart Disease.
    Nollet E; Hoymans VY; Rodrigus IR; De Bock D; Dom M; Vanassche B; Van Hoof VO; Cools N; Van Ackeren K; Wouters K; Vermeulen K; Vrints CJ; Van Craenenbroeck EM
    J Cardiovasc Transl Res; 2016 Aug; 9(4):266-78. PubMed ID: 27456951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved functional activity of bone marrow derived circulating progenitor cells after intra coronary freshly isolated bone marrow cells transplantation in patients with ischemic heart disease.
    Turan RG; Bozdag-T I; Ortak J; Kische S; Akin I; Schneider H; Turan CH; Rehders TC; Rauchhaus M; Kleinfeldt T; Belu C; Brehm M; Yokus S; Steiner S; Sahin K; Nienaber CA; Ince H
    Stem Cell Rev Rep; 2011 Sep; 7(3):646-56. PubMed ID: 21188654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow-derived progenitor cells in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
    Pescini F; Cesari F; Giusti B; Sarti C; Zicari E; Bianchi S; Dotti MT; Federico A; Balestrino M; Enrico A; Gandolfo C; Gori AM; Abbate R; Pantoni L; Inzitari D
    Stroke; 2010 Feb; 41(2):218-23. PubMed ID: 20035077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating apoptotic progenitor cells: a novel biomarker in patients with acute coronary syndromes.
    Schwartzenberg S; Deutsch V; Maysel-Auslender S; Kissil S; Keren G; George J
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):e27-31. PubMed ID: 17332488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of exercise training on mobilization and functional activity of blood-derived progenitor cells in patients with acute myocardial infarction.
    Brehm M; Picard F; Ebner P; Turan G; Bölke E; Köstering M; Schüller P; Fleissner T; Ilousis D; Augusta K; Peiper M; Schannwell Ch; Strauer BE
    Eur J Med Res; 2009 Sep; 14(9):393-405. PubMed ID: 19748858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating progenitor cells and outcomes in patients with coronary artery disease.
    Dhindsa DS; Desai SR; Jin Q; Sandesara PB; Mehta A; Liu C; Tahhan AS; Nayak A; Ejaz K; Hooda A; Moazzami K; Islam SJ; Rogers SC; Almuwaqqat Z; Mokhtari A; Hesaroieh I; Ko YA; Sperling LS; Waller EK; Quyyumi AA
    Int J Cardiol; 2023 Feb; 373():7-16. PubMed ID: 36460208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow resident and circulating progenitor cells in patients undergoing cardiac surgery.
    Dotsenko O; Xiao Q; Xu Q; Jahangiri M
    Ann Thorac Surg; 2010 Dec; 90(6):1944-51. PubMed ID: 21095342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
    Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
    Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating angiogenic cytokines and stem cells in patients with severe chronic ischemic heart disease--indicators of myocardial ischemic burden?
    Ripa RS; Wang Y; Goetze JP; Jørgensen E; Johnsen HE; Tägil K; Hesse B; Kastrup J
    Int J Cardiol; 2007 Aug; 120(2):181-7. PubMed ID: 17157396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial progenitor cells, atheroma burden and clinical outcome in patients with coronary artery disease.
    Padfield GJ; Tura-Ceide O; Freyer E; Barclay GR; Turner M; Newby DE; Mills NL
    Heart; 2013 Jun; 99(11):791-8. PubMed ID: 23390050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.